AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

📰

Stroke disorder: the latest breakthroughs

Everything that changed in the last year, from three public sources: phase 3 trials that posted their results, papers in the leading medical and cancer journals, and US drug labels that were updated. Refreshed every week.

🤖

What changed

Written by AI from the evidence below, every point cited

AI reads the results, papers and label updates below and explains what changed and why it matters, citing each source. It is shared with everyone.

🏁

Phase 3 results posted

The large trials that decide new standard treatments · ClinicalTrials.gov
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or StrokeNCT03872401 · results posted 2026-06-25 · Amgen · 12301 people · tests Evolocumab, Placebo Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb SpasticityNCT04815967 · results posted 2026-05-27 · Solstice Neurosciences, LLC, a subsidiary of MDD … · 32 people · tests Phase 2; Low Dose MYOBLOC (10,000 Units), Phase 2; High Dose MYOBLOC (20,000 Units), Phas… Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb SpasticityNCT04099667 · results posted 2026-05-22 · Solstice Neurosciences, LLC, a subsidiary of MDD … · 40 people · tests Phase 2; Low Dose MYOBLOC (15,000 Units), Phase 2; High Dose MYOBLOC (20,000 Units), Phas… Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial FibrillationNCT03702582 · results posted 2026-05-19 · Massachusetts General Hospital · 100 people · tests Rivaroxaban, Warfarin Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and OutcomesNCT02850081 · results posted 2026-05-07 · Columbia University · 31 people · tests Statin, Atorvastatin, Placebo Phone-based Intervention Under Nurse Guidance After Stroke 2NCT04404166 · results posted 2026-01-30 · Northern California Institute of Research and Edu… · 500 people · tests PINGS 2, Standard of Care Maimonides Minocycline in Stroke StudyNCT06107725 · results posted 2025-12-17 · Maimonides Medical Center · 2 people · tests Minocycline Efficacy and Safety of Mexidol® in Stroke TherapyNCT06437626 · results posted 2025-12-08 · Pharmasoft · 304 people · tests Mexidol (Ethylmethylhydroxypyridine Succinate), Placebo
🏛️

US drug labels updated

A label changes when a new use, dose or warning is approved · openFDA

No label updates found.

An update is not always a new approval — open the label to see what changed.

Want these every week? Follow stroke disorder and get a note on your phone with the new trials and papers.

🔔 Follow stroke disorder
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy